Ideas
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
9:33
AI capex cycle intact, buy the dip.
The AI-driven capex cycle remains intact with ~80% probability that hyperscalers will not retreat on investment. Temporary noise (Samsung earnings slightly below consensus, HBM margin drag, decelerating DRAM price growth) has created a pullback, but valuations are now very cheap: KOSPI forward P/E ~6.4x, SK hynix P/E ~5x, Samsung ex-charge floor around 28,000-30,000 KRW. Earnings trajectory continues upward, and the long-term AI infrastructure build-out (involving government and enterprise) is far from over. He expects Samsung Electronics and SK hynix can reclaim their previous highs once hyperscaler earnings in late July reaffirm capex plans.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
12:32
Buy ADR, sell local on premium.
UBS and other global desks are recommending a pair trade: buy the new SK hynix ADR (listing Friday) and sell the local Seoul-listed shares to capture the typical ADR premium observed with names like TSMC. The premium could be 15–20% initially but tends to converge over time. This arbitrage flow is driving near-term foreign selling of local SK hynix shares.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
36:27
Samsung preferred discount will narrow.
Samsung Electronics preferred shares offer a better entry than common shares due to a persistent discount. As the common shares recover, the discount should narrow, providing additional relative upside.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
37:00
Korean biotech ETF to converge with XBI.
A striking divergence has opened: the US XBI biotech ETF is hitting new highs (+32% YTD) while the Korean KODEX Biotech ETF is down -30%. Historically the two have very tight correlation with only a time lag. With the macro environment not hostile to growth stocks (Powell likely holding rates until September, no immediate inflation or employment fears), there is a strong case for Korean biotech to converge upward toward its US counterpart.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
39:55
Shipbuilding orders booming, Hyundai Heavy top pick.
Korean shipbuilders, especially HD Hyundai Heavy Industries (top pick), have already achieved most annual order targets by July. The next leg of the cycle will come from non-container ship demand: offshore plants, special-purpose vessels, military contracts, and engines. The order momentum remains very strong and he argues the sector should not be stopped out.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
47:28
HYBE earnings explosion, valuation near historical low.
HYBE is a bottom-fishing opportunity. Earnings are surging: full-year revenue is expected to exceed KRW 4 trillion (up from KRW 2.6 trillion last year), operating profit jumped from KRW 50 billion to KRW 300 billion, and Q2 operating profit grew 147% YoY. The P/E has fallen to around 20x, an extremely low level for the entertainment sector historically. BTS comebacks, MD sales, and offline concerts are only beginning to be reflected and should drive further upside through the second half.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
49:36
Celltrion earnings strong despite low expectations.
Celltrion is a stock to accumulate. Sentiment and consensus expectations are at rock bottom, but the company has already shown improving earnings in Q2 and he expects the strong earnings trajectory to continue. It is a contrarian play on Korean biotech that could benefit once the sector sees a brief easing of pessimism.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
53:06
Tesla robot reveal will reignite robotics narrative.
Tesla will unveil its third-generation humanoid robot in late July. This event can reignite the global humanoid and robotics narrative, which has been the core driver of Tesla's stock momentum. A successful reveal could lift Tesla and the broader robot value chain globally.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
53:43
Robot narrative may save Hyundai Motor.
Hyundai Motor faces a near-term earnings shock in Q2 but is expected to turn around from Q3. The bigger catalyst is robotics: Tesla's robot event could lift the entire robot value chain, and Hyundai owns Boston Dynamics. Although meaningful robot revenue is not expected until 2028, the narrative could provide a breath of life for the stock, provided management accelerates related corporate actions and listing plans.
This 3PRO TV (삼프로TV) video, published July 08, 2026,
features Park Ji-hoon
discussing 005930.KS, 000660.KS, SK Hynix ADR, 005935.KS, 114800.KS, 329180.KS, 010140.KS, 042660.KS, 352820.KQ, 068270.KS, TSLA, 005380.KS.
9 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Park Ji-hoon
· Tickers:
005930.KS,
000660.KS,
SK Hynix ADR,
005935.KS,
114800.KS,
329180.KS,
010140.KS,
042660.KS,
352820.KQ,
068270.KS,
TSLA,
005380.KS
